Cefepime: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Cefepime | |||
Cefepime is a fourth-generation [[cephalosporin]] [[antibiotic]] developed in 1994. Cefepime has an extended spectrum of activity against [[Gram-positive]] and [[Gram-negative]] [[bacteria]], with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime hydrochloride was first marketed in 1994 and is currently marketed under various trade names including Maxipime ([[Elan Pharma]]), Maxcef, Cepimax, Cepimex, and Axepim. | |||
==Category== | ==Category== | ||
Cephalosporin, Fourth-Generation | Cephalosporin, Fourth-Generation | ||
==US Brand Names== | ==US Brand Names== | ||
MAXIPIME<sup>®</sup> | MAXIPIME<sup>®</sup> | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
'''[[Cefepime description|Description]]''' | |||
''' [[Cefepime description|Description]]''' | |||
'''| [[Cefepime clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Cefepime clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Cefepime microbiology|Microbiology]]''' | '''| [[Cefepime microbiology|Microbiology]]''' | ||
Revision as of 01:47, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime hydrochloride was first marketed in 1994 and is currently marketed under various trade names including Maxipime (Elan Pharma), Maxcef, Cepimax, Cepimex, and Axepim.
Category
Cephalosporin, Fourth-Generation
US Brand Names
MAXIPIME®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages